Kuhns, Lisa M.
Garofalo, Robert
Belzer, Marvin
McAvoy-Banerjea, Julie
Holzman, Jesse
Kwak, Eun
Johnson, Amy K.
Biello, Katie
Schnall, Rebecca
Hidalgo, Marco A.
Reisner, Sari L.
Mimiaga, Matthew J.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U01AI156875)
Article History
Received: 6 January 2025
Accepted: 30 November 2025
First Online: 17 December 2025
Declarations
:
: The Ann & Robert H. Lurie Children’s Hospital of Chicago institutional review board approved the protocol presented in this paper (IRB no. 2021-4086). This trial is registered at ClinicalTrials.gov (NCT05018611). All participants provide informed written consent prior to initiating study activities and can withdraw from the study at any time without consequence. Data sets are coded with a participant identification number. All study staff participate in the required trainings for the conduct of studies that involve human subjects, which includes (but is not limited to) human subjects, informed consent, and good clinical practice.
: Not applicable.
: The authors declare that they have no competing interests.